The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Oncolytic Virus Immunotherapy Market Research Report 2025

Global Oncolytic Virus Immunotherapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1933950

No of Pages : 76

Ask Your Query

Synopsis

Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).

The global Oncolytic Virus Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.

This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Immunotherapy.

Report Scope

The Oncolytic Virus Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncolytic Virus Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Merck
  • Amgen
  • TILT Biotherapeutics
  • Oncorus
  • Sorrento Therapeutics
  • Shanghai Sunway Biotech

Segment by Type

  • Engineering Oncolytic Viruses
  • Wild-Type Oncolytic Viruses

Segment by Application

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Engineering Oncolytic Viruses
1.2.3 Wild-Type Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Immunotherapy Market Perspective (2019-2030)
2.2 Oncolytic Virus Immunotherapy Growth Trends by Region
2.2.1 Global Oncolytic Virus Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncolytic Virus Immunotherapy Historic Market Size by Region (2019-2024)
2.2.3 Oncolytic Virus Immunotherapy Forecasted Market Size by Region (2025-2030)
2.3 Oncolytic Virus Immunotherapy Market Dynamics
2.3.1 Oncolytic Virus Immunotherapy Industry Trends
2.3.2 Oncolytic Virus Immunotherapy Market Drivers
2.3.3 Oncolytic Virus Immunotherapy Market Challenges
2.3.4 Oncolytic Virus Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue
3.1.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue (2019-2024)
3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Immunotherapy Revenue
3.4 Global Oncolytic Virus Immunotherapy Market Concentration Ratio
3.4.1 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Immunotherapy Revenue in 2023
3.5 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Immunotherapy Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Immunotherapy Breakdown Data by Type
4.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Type (2019-2024)
4.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2025-2030)
5 Oncolytic Virus Immunotherapy Breakdown Data by Application
5.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Application (2019-2024)
5.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncolytic Virus Immunotherapy Market Size (2019-2030)
6.2 North America Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oncolytic Virus Immunotherapy Market Size by Country (2019-2024)
6.4 North America Oncolytic Virus Immunotherapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Immunotherapy Market Size (2019-2030)
7.2 Europe Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oncolytic Virus Immunotherapy Market Size by Country (2019-2024)
7.4 Europe Oncolytic Virus Immunotherapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Immunotherapy Market Size (2019-2030)
9.2 Latin America Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2019-2024)
9.4 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Immunotherapy Market Size (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Oncolytic Virus Immunotherapy Introduction
11.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Oncolytic Virus Immunotherapy Introduction
11.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 TILT Biotherapeutics
11.3.1 TILT Biotherapeutics Company Detail
11.3.2 TILT Biotherapeutics Business Overview
11.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction
11.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2019-2024)
11.3.5 TILT Biotherapeutics Recent Development
11.4 Oncorus
11.4.1 Oncorus Company Detail
11.4.2 Oncorus Business Overview
11.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction
11.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2019-2024)
11.4.5 Oncorus Recent Development
11.5 Sorrento Therapeutics
11.5.1 Sorrento Therapeutics Company Detail
11.5.2 Sorrento Therapeutics Business Overview
11.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction
11.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2019-2024)
11.5.5 Sorrento Therapeutics Recent Development
11.6 Shanghai Sunway Biotech
11.6.1 Shanghai Sunway Biotech Company Detail
11.6.2 Shanghai Sunway Biotech Business Overview
11.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction
11.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2019-2024)
11.6.5 Shanghai Sunway Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Engineering Oncolytic Viruses
Table 3. Key Players of Wild-Type Oncolytic Viruses
Table 4. Global Oncolytic Virus Immunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Oncolytic Virus Immunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Oncolytic Virus Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Oncolytic Virus Immunotherapy Market Share by Region (2019-2024)
Table 8. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Oncolytic Virus Immunotherapy Market Share by Region (2025-2030)
Table 10. Oncolytic Virus Immunotherapy Market Trends
Table 11. Oncolytic Virus Immunotherapy Market Drivers
Table 12. Oncolytic Virus Immunotherapy Market Challenges
Table 13. Oncolytic Virus Immunotherapy Market Restraints
Table 14. Global Oncolytic Virus Immunotherapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Oncolytic Virus Immunotherapy Market Share by Players (2019-2024)
Table 16. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2023)
Table 17. Ranking of Global Top Oncolytic Virus Immunotherapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Oncolytic Virus Immunotherapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oncolytic Virus Immunotherapy Product Solution and Service
Table 21. Date of Enter into Oncolytic Virus Immunotherapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oncolytic Virus Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2019-2024)
Table 25. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2025-2030)
Table 27. Global Oncolytic Virus Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2019-2024)
Table 29. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2025-2030)
Table 31. North America Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Oncolytic Virus Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Oncolytic Virus Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Oncolytic Virus Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Oncolytic Virus Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Oncolytic Virus Immunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Oncolytic Virus Immunotherapy Product
Table 49. Merck Revenue in Oncolytic Virus Immunotherapy Business (2019-2024) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen Oncolytic Virus Immunotherapy Product
Table 54. Amgen Revenue in Oncolytic Virus Immunotherapy Business (2019-2024) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. TILT Biotherapeutics Company Detail
Table 57. TILT Biotherapeutics Business Overview
Table 58. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product
Table 59. TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2019-2024) & (US$ Million)
Table 60. TILT Biotherapeutics Recent Development
Table 61. Oncorus Company Detail
Table 62. Oncorus Business Overview
Table 63. Oncorus Oncolytic Virus Immunotherapy Product
Table 64. Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2019-2024) & (US$ Million)
Table 65. Oncorus Recent Development
Table 66. Sorrento Therapeutics Company Detail
Table 67. Sorrento Therapeutics Business Overview
Table 68. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product
Table 69. Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2019-2024) & (US$ Million)
Table 70. Sorrento Therapeutics Recent Development
Table 71. Shanghai Sunway Biotech Company Detail
Table 72. Shanghai Sunway Biotech Business Overview
Table 73. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product
Table 74. Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2019-2024) & (US$ Million)
Table 75. Shanghai Sunway Biotech Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Immunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oncolytic Virus Immunotherapy Market Share by Type: 2023 VS 2030
Figure 3. Engineering Oncolytic Viruses Features
Figure 4. Wild-Type Oncolytic Viruses Features
Figure 5. Global Oncolytic Virus Immunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Oncolytic Virus Immunotherapy Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Oncolytic Virus Immunotherapy Report Years Considered
Figure 11. Global Oncolytic Virus Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Oncolytic Virus Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Oncolytic Virus Immunotherapy Market Share by Region: 2023 VS 2030
Figure 14. Global Oncolytic Virus Immunotherapy Market Share by Players in 2023
Figure 15. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Oncolytic Virus Immunotherapy Revenue in 2023
Figure 17. North America Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Oncolytic Virus Immunotherapy Market Share by Country (2019-2030)
Figure 19. United States Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Oncolytic Virus Immunotherapy Market Share by Country (2019-2030)
Figure 23. Germany Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Oncolytic Virus Immunotherapy Market Share by Region (2019-2030)
Figure 31. China Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Oncolytic Virus Immunotherapy Market Share by Country (2019-2030)
Figure 39. Mexico Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Oncolytic Virus Immunotherapy Market Share by Country (2019-2030)
Figure 43. Turkey Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Oncolytic Virus Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2019-2024)
Figure 46. Amgen Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2019-2024)
Figure 47. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2019-2024)
Figure 48. Oncorus Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2019-2024)
Figure 49. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2019-2024)
Figure 50. Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock